ABSTRACT
Objective:To study the effect of different hemostasis methods on postoperative pain and sex hormone levels in patients undergoing laparoscopic ovarian cystectomy.Methods:A total of 118 patients with ovarian cysts admitted to our hospital from Jun. 2018.6 to Aug. 2020 were collected and grouped by digital table method into electrocoagulation hemostasis group (59 cases, electrocoagulation hemostasis) and suture hemostasis group (59 cases, suture hemostasis). Pain at time points, serum inflammatory factors and sex hormone levels in the two groups were measured, and the incidence of complications was counted 12 weeks after surgery.Results:The VAS scores of suture hemostasis group at 6, 12 and 24 h after operation (3.33±0.93, 3.63±1.02, 3.01±0.94) were significantly lower than those of the electrocoagulation hemostasis group (4.16±1.05, 4.61±1.17, 3.72±1.05) ; there was no significant difference in serum interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) levels between the preoperative suture hemostasis group and the electrocoagulation hemostasis group. The serum levels of IL-6 and TNF-α in the group (37.64±4.82ng/L, 39.67±4.71ng/L) were lower than those in the electrocoagulation hemostasis group (45.96±5.25ng/L, 48.96±5.14ng/L) ( P<0.05) .) ; there was no significant difference in serum follicle-stimulating hormone (FSH), estradiol (E 2) or luteinizing hormone (LH) levels between preoperative electrocoagulation hemostasis group and suture hemostasis group ( P>0.05) ; There was no significant difference in the three indexes in the suture hemostasis group 3 months after operation compared with those before treatment ( P>0.05). The serum FSH and LH [ (6.59±0.91) mIU/ml, (5.24±0.77) mIU/ml] in the suture hemostasis group were lower than those in the electrocoagulation hemostasis group [ (7.39±1.02) mIU/m, (5.97±0.89) mIU/m], E 2 in suture hemostasis group [ (51.08±6.09) pg/ml] was higher than that in electrocoagulation hemostasis group [ (46.88±5.59) pg/ml] ( P<0.05). In terms of the complication rate at 3 months after operation, the suture hemostasis group (32.20%) was significantly lower than electrocoagulation hemostasis (13.56%) ( P<0.05). After 1 year of follow-up, the pregnancy success rate of the suture hemostasis group (72.88%) was significantly higher than that of the electrocoagulation hemostasis group (52.54%) ( P<0.05). There was no significant difference in pregnancy outcomes ( P>0.05) . Conclusions:Suture hemostasis in patients undergoing laparoscopic ovarian cystectomy is beneficial to relieve postoperative pain, improve postoperative inflammatory response, protect their ovarian function, avoid complications such as abnormal ovulation and excessive menstrual flow, and improve the success rate of pregnancy. The overall application effect is better than electrocoagulation hemostasis.
ABSTRACT
Objective:To evaluate the curative effect of self-made Xingqi Jiedu Decoction combined with goserelin for endometriosis (EMT).Methods:Randomized controlled trial. A total of 84 patients with EMT in the hospital were enrolled as observation objects between July 2019 and July 2021. According to random number table method, they were divided into the control group (subcutaneous injection of goserelin) and the observation group (self-made Xingqi Jiedu Decoction on basis of control group), 42 in each group. All were treated for 6 months. TCM syndromes were scored before and after treatment. The severity of pelvic pain was evaluated by VAS. The levels of FSH, LH and estradiol (E 2) were detected by full-automatic chemiluminescence immunoassay and corresponding reagents, and levels of serum IL-1β, IL-8 and TNF-α were detected by ELISA. The adverse events were recorded, and clinical curative effect was evaluated. Results:The differences in total response rate between observation group and control group was statistically significant [95.24% (40/42) vs. 80.95% (34/42); χ2=4.09, P=0.043]. After treatment, scores of TCM syndromes and VAS in observation group were significantly lower than those in the control group ( t=14.30, 7.32, P<0.01). After treatment, FSH [(5.36±1.03) U/L vs. (6.20±1.35) U/L, t=3.21], E 2[(230.57±36.84) pmol/L vs. (265.28±37.53) pmol/L, t=4.28] and LH [(8.15±1.18) U/L vs. (9.24±2.01) U/L, t=3.03] in the observation group were significantly lower than those in the control group ( P<0.01). The levels of IL-1β, IL-8 and TNF-α in the observation group were significantly lower than those in the control group ( t=5.05, 5.07, 3.82, P<0.01). During treatment, differences in incidence of adverse reactions between observation group and control group was statistically significant [19.05% (8/42) vs. 4.76% (2/42); χ2=4.09, P=0.043]. Conclusion:The self-made Xingqi Jiedu Decoction combined with goserelin can improve hormone level, inhibit inflammatory response and improve clinical curative effect in EMT patients.
ABSTRACT
Background: Hypothyroidism is known to interfere with the metabolism of all the cells in the body, particularly fat metabolism inadipose tissue. This, in turn, leads to obesity. Body mass index (BMI) is widely used to assess obesity and metabolic syndrome.Obesity leads to a higher incidence of cardiovascular morbidity and mortality.Materials and Methods: Twenty-five hypothyroid subjects were enrolled (study group) from the Department of Endocrinologyand Metabolism, Govt. Rajaji Hospital attached to the Madurai Medical College, Madurai. Twenty-five normal subjects whowere age- and sex-matched with the study group were enrolled to form the control group. Serum levels of thyroid-stimulatinghormone (TSH), total circulating T4, and total circulating T3 were measured by radioimmunoassay to confirm hypothyroidism.Height and weight were measured using a stadiometer and weighing scale, BMI was calculated using Quetelet’s index formula.Results and Conclusion: The results were tabulated and analyzed by applying unpaired t-test and SPSS software version16.0. BMI values of the study group and control group were compared, but there was no statistical significance. BMI valueswhen compared with serum TSH levels within the same group, the Pearson correlation coefficient also showed no statisticalsignificance.
ABSTRACT
Background: Hypothyroidism has been known to be associated with changes in systemic arterial blood pressure. Diastolicblood pressure (DBP) is known to be elevated causing proportionate reduction in pulse pressure.Aim: The aim of the study is to find out the correlation between systolic blood pressure (SBP), DBP, pulse pressure (PP), andmean arterial pressure of hypothyroid patients and normal individuals.Materials and Methods: This case–control study was conducted in Government Rajaji Hospital attached to Madurai MedicalCollege, Madurai. Twenty-five hypothyroid subjects were enrolled for the study (study group) from the department of endocrinologyand metabolism. Twenty-five normal subjects who were age and sex matched with the study group were enrolled for the study(control group). Serum thyroid-stimulating hormone (TSH) levels were estimated in all the subjects. Arterial blood pressure wasrecorded in all the subjects in the sitting posture and the results obtained. The results are tabulated and analyzed by applyingunpaired “t” test.Results and Conclusion: Among the blood pressure parameters, only PP showed a positive correlation between the studygroup and control group. SBP, DBP, and mean arterial blood pressure showed no significance.
ABSTRACT
Objective To investigate the relationship between serum markers β amyloid (Aβ), tau and thyroid hormone levels and post-stroke cognitive impairment (PSCI) in the acute phase of cerebral infarction. Methods A total of 214 patients with acute cerebral infarction were enrolled. The baseline data and serological indicators were collected and the cognitive function of patients was evaluated. All patients were divided into cognitive impairment group and normal group based on follow-up results. The differences of Aβ1-42, tau protein and thyroxine levels between the two groups and their relationship with disease progression were analyzed. The Cox regression analysis and ROC curve were used to compare the above parameters to predict the development of PSCI. Results The total protein level of Tau (210.6 ±98.9 pg/mL) was higher and Aβ1-42 (426.1 ±123.5 pg/mL) and triiodothyronine (T3) (1.43 ±0.57 nmol/L), free thyroxine (FT4) (13.15±2.23 pmol/L) was significantly lower in the cognitive impairment group than in the normal group (P<0.05). Tau protein (r=-0.457), Aβ1-42 (r=0.348), T3 (r=0.211), and FT4 (r=0.306) were all associated with disease progression (P<0.05). Cox regression analysis showed that Aβ1-42 and T3 were important influencing factors in the occurrence of PSCI. The area under the curve of Aβ1-42 combined with T3 was 0.841. The specificity and the sensitivity were 74.8% and 85.3%, respectively, with a diagnostic cutoff value of 0.572. Conclusion Aβ1-42 and T3 levels in the acute phase of cerebral infarction may predict the progression of PSCI.
ABSTRACT
Objective Diabetes mellitus (DM) is often complicated by thyroid hormone abnormality. The aim of this study was to investigate the relationship between the thyroid hormone level and glycemic fluctuation in patients with euthyroid type 2 DM (T2DM).Methods A total of 143 euthyroid T2DM patients were treated in the Department of Endocrinology of Nanjing General Hospital from January 2014 to December 2015. The continuous blood glucose monitoring system was used for 72-hour continuous monitoring of blood glucose fluctuation indexes, including the standard deviation (SD) of the glucose level, the mean amplitude of glycemic excursions (MAGE), and the absolute mean of daily differences (MODD). According to the percentile of the MAGE level, the patients were divided into groups Q1 (MAGE<4.1864, n=35), Q2 (4.1864≤MAGE<5.3764, n=37), Q3 (5.3764≤MAGE<6.8484, n=35), and Q4 (MAGE≥6.8484, n=36), compared the thyroid hormone level and such thyroid function parameters as serum free triiodothyronine (FT3), triiodothyronine (T3), free thyroxine (FT4) and FT3/FT4 among the four groups, and analyzed the correlation between the thyroid hormone level and glycemic indexes.Results The levels of serum FT3, T3 and FT3/FT4 were decreased with the increase of MAGE (P<0.05), and those of FT3 and FT3/FT4 were 4.11±0.77 and 0.38±0.37 in group Q1, 4.06±0.55 and 0.34±0.37 in Q2, 3.49±0.57 and 0.33±0.06 in Q3, and 3.68±0.65 and 0.31±0.09 in Q4, with statistically significant differences between any two groups (P<0.05). There were also statistically significant differences among the four groups (P<0.05) in the T3 and FT4 levels (P<0.05). The levels of FT3 and T3 were correlated negatively with SD, MODD and MAGE (P<0.05), and so was that of FT3/FT4 with MAGE (r=-0.243, P<0.05).Conclusion MAGE reduces the levels of FT3 and FT3/FT4 in patients with euthyroid T2DM probably by inhibiting the conversion of T4 to T3.
ABSTRACT
Objective:To observe and research the diagnostic value of enhanced MRI of pituitary for pituitary stalk interruption syndrome (PSIS) and explore the correlation between enhanced MRI and pituitary target gland function damage.Methods: 80 patients with PSIS were divided into part of pituitary stalk interruption group (38cases) and complete pituitary stalk interruption group (42cases). And 80 healthy people were divided into control group. The relative hormonal level of three groups were detected, and the correlation between appearance of MRI and insufficient hormonal type, amount and severity degree were analyzed.Results: In part of pituitary stalk interruption group, the heights of anterior pituitary gland were less than 3mm in 10 cases, and they were between 3-5mm in 23 cases and they were more than 5mm in 5 cases. And in them, there were 4 cases were posterior pituitary deficiency, 15 cases were heterotopia, 11 cases were volume diminished. In complete pituitary stalk interruption group, the heights of anterior pituitary gland were less than 3mm in 23 cases, and they were between 3-5mm in 16 cases and they were more than 5mm in 3 cases. And in them, there were 8 cases were posterior pituitary deficiency, 32 cases were heterotopia, 1 cases were volume diminished. All of the hormonal levels included growth hormone, insulin-like growth factor, free thyroxine, serum thyroid stimulating hormone (TSH), cortisol and adrenocorticotrophic hormone (ACTH) in complete pituitary stalk interruption group were significantly lower than that in part of pituitary stalk interruption group and control group (F=224.92,F=2571.80, F=369.50,F=67.73,F=2677.94,F=24.17,P<0.05), respectively. The differences of growth hormone, TSH, cortisol and ACTH, excepted insulin-like growth factor and free thyroxine, between part of pituitary stalk interruption group and control group were not significant. And pituitary-gonadal hormones level of part of pituitary stalk interruption group was significantly lower than that of control group (F=354.94,F=247.00, F=247.83,F=655.05,F=48.10,P<0.05). Besides, the differences of follicle-stimulating hormone, luteinizing hormone, estradiol, testosterone and prolactin levels between part of pituitary stalk interruption group and complete pituitary stalk interruption group were no significant.Conclusion: Enhanced MRI of pituitary can effectively diagnose pituitary stalk interruption syndrome and damage degree of pituitary target gland function.
ABSTRACT
Objective To observe the effect of Rule Granules on the breast tissue pathology,ovarian hormone and receptor expression of mammary glands hyperplasia rats; To explore its mechanism of action. Methods The model of mammary gland hyperplasia was established by intramuscular injection of estradiol benzoate for 20 days and intramuscular injection of progesterone for 5 d. 66 female SD rats were randomly divided into 6 groups, including blank group, model group, acupuncture group, TCM high-, medium- and low-dose groups, with 11 rats in each group. Acupuncture group chose group A (Wuyi, Hegu, on both sides, Tanzhong) and group B (Tianzong, Ganshu, Zusanli, on both sides), and the two groups were used alternately, one group per day. TCM groups received 1.1 g/mL, 0.55 g/mL,and 0.11 g/mL dose of Rule Granules for gavage,once a day.Abdominal aorta blood was collected after continuous treatment of 30 d. The contents of serum E2and P were detected through ELISA method, at the same time, the second left side of the breast was removed. The changes of the breast tissue was observed under light microscope, and the ER and PR positive expression was observed by SABC immunohistochemical method. Results Compared with the blank group, hyperplasia of mammary gland in the model group rats was more obvious, and serum E2, ER and PR positive expression of integral increased significantly (P<0.01), but the content of P decreased significantly (P<0.01); compared with the model group, hyperplasia of mammary gland was improved in all treatment groups, and serum E2, ER and PR positive expression of integral decreased significantly (P<0.05); the content of P in acupuncture group increased significantly (P<0.01), and the acupunture group and TCM low-dose group were the most obvious. Conclusion Rule Granules can effectively improve hyperplasia of mammary gland organization structure in rats caused by exogenous estrogen and progesterone, with TCM low-dose group and acupuncture group having the best efficacy. Its mechanism is related to reducing the contents of serum E2and ER, and PR positive expression in breast tissue, and increasing the content of serum P.
ABSTRACT
Objective To observe the effect of Rule Granules on the breast tissue pathology,ovarian hormone and receptor expression of mammary glands hyperplasia rats; To explore its mechanism of action. Methods The model of mammary gland hyperplasia was established by intramuscular injection of estradiol benzoate for 20 days and intramuscular injection of progesterone for 5 d. 66 female SD rats were randomly divided into 6 groups, including blank group, model group, acupuncture group, TCM high-, medium- and low-dose groups, with 11 rats in each group. Acupuncture group chose group A (Wuyi, Hegu, on both sides, Tanzhong) and group B (Tianzong, Ganshu, Zusanli, on both sides), and the two groups were used alternately, one group per day. TCM groups received 1.1 g/mL, 0.55 g/mL,and 0.11 g/mL dose of Rule Granules for gavage,once a day.Abdominal aorta blood was collected after continuous treatment of 30 d. The contents of serum E2and P were detected through ELISA method, at the same time, the second left side of the breast was removed. The changes of the breast tissue was observed under light microscope, and the ER and PR positive expression was observed by SABC immunohistochemical method. Results Compared with the blank group, hyperplasia of mammary gland in the model group rats was more obvious, and serum E2, ER and PR positive expression of integral increased significantly (P<0.01), but the content of P decreased significantly (P<0.01); compared with the model group, hyperplasia of mammary gland was improved in all treatment groups, and serum E2, ER and PR positive expression of integral decreased significantly (P<0.05); the content of P in acupuncture group increased significantly (P<0.01), and the acupunture group and TCM low-dose group were the most obvious. Conclusion Rule Granules can effectively improve hyperplasia of mammary gland organization structure in rats caused by exogenous estrogen and progesterone, with TCM low-dose group and acupuncture group having the best efficacy. Its mechanism is related to reducing the contents of serum E2and ER, and PR positive expression in breast tissue, and increasing the content of serum P.
ABSTRACT
<p><b>OBJECTIVE</b>To discuss the therapeutic effects of electroacupuncture on benign prostatic hyperplasia and the impacts on hormone levels in the patients.</p><p><b>METHODS</b>Sixty patients were randomized into an electroacupuncture group and a medication group, 30 cases in each one. In the electroacupuncture group, electroacupuncture was applied to Zhongji (CV 3) and Qugu (CV 2), once a day, 5 times a week. In the medication group, tamsulosin hydrochloride sustained-release capsules were prescribed for oral administration, 0.2 mg, once a day. The duration of treatment was 6 weeks in both of the two groups. The changes in serum testosterone (T), estradiol (E) and E/T, the international prostate symptom score (IPSS) and its erectile function score (ⅡEF5) and serum prostate specific antigen (PSA) as well as the adverse reactions were observed before and after treatment in the two groups. The clinical therapeutic effects were compared between the two groups.</p><p><b>RESULTS</b>Before and after treatment, the differences in serum T, Eand E/T were not significant in the electroacupuncture group (all>0.05); the difference in E/T was significant in the medication group (<0.05). The differences in serum T, Eand E/T were not significant between the two groups (all>0.05). IPSS was reduced as compared with that before treatment in the electroacupuncture group (<0.05) and was not different significantly as compared with that before treatment in the medication group (>0.05). The difference was significant in comparison of the two groups after treatment (<0.05), and the electroacupuncture group was better. After treatment, the symptom severity was reduced apparently in the electroacupuncture group and the overall situation was better than that in the medication group (<0.05). ⅡEF5 score and PSA were not different significantly before and after treatment in the two groups and between the two groups (all>0.05). The total effective rate was 60.7% (17/28) in the electroacupuncture group, apparently better than 30.8% (8/26,<0.05) in the the medication group.</p><p><b>CONCLUSIONS</b>Electroacupucnture at Zhongji (CV 3) and Qugu (CV 2) apparently relieves the symptoms in the patients and the therapeutic effects are better than the oral administration of tamsulosin hydrochloride sustained-release capsules, but electroacupuncture has not apparent impacts on serum T and Elevels.</p>
ABSTRACT
Objective Through testicular biopsy and detection of serum sex hormone levels in patients with azoospermia,to explore the relationship between spermatogenic function of testis,testicular volume and serum LH and FSH levels.Methods 80 cases of azoospermia patients adimitted from Jan.2012 to Dec.2014 were collected as the research object.Immunization method was used to detect the serum sex hormone leve,testis model was adopted to detect testicular volume,and routine disinfection was given to make testicular biopsy.According to testicular biopsy results,patients were divided into normal spermatogenic function group (group A),spermatogenic dysfunction group (group B),sertoli-cell-only syndrome group (group C);percutaneous sperm group (group D),and puncture azoospermia group (group E).At the same time,50 cases of healthy male were selected as the control group and they received sperm routine examination and sex hormone detection.Correlation between spermatogenic function of testis,testicular volume and serum LH and FSH levels were studied.Results Serum levels of LH and FSH had no significant difference among group A,group B and the control group (P＞0.05).Serum level of LH and FSH was significantly higher in group C than that in group A,group B and the control group,and the differences had statistical significance (P＜0.05).Serum level of LH and FSH in group D had no significant difference compared with that of the control group (P＞0.05).Serum level of LH and FSH in group E was significantly higher than that in group D and the control group,and the difference had statistical significance (P＜0.05).The level of LH and FSH was significantly higher in abnormal testicular group than that in normal testis group,and the difference had statistical significance (P＜0.05).Spearman correlation analysis showed that the spermatogenic function of testis was negatively correlated with serum LH and FSH levels (r=-0.473,-0.441,P＜0.05).Testicular volume was negatively correlated with serum LH and FSH levels(r=-0.643,-0.715,P＜0.05),and the difference had statistical significance.Conclusion The determination of serum LH and FSH levels has important clinical value for predicting testicular spermatogenic function in azoospermia patients,and can be used to guide clinical puncture and prognosis judgement.
ABSTRACT
OBJECTIVE:To observe the efficacy and safety of mifepristone cycle therapy in the treatment of perimenopausal dysfunctional uterine bleeding. METHODS:Totally 116 patients with perimenopausal dysfunctional uterine bleeding were randomly divided into control group and observation group. Control group was given Mifepristone tablet 10 mg from 3 d after diagnostic cu-rettage on an empty stomach for continuous 90 d,once a day. Observation group was given Mifepristone tablet 10 mg from 3 d af-ter diagnostic curettage on an empty stomach,once a day,and it was stopped after continuous 5 d. Then it continued 5 d from the first day of menstruation,and lasted 3 menstrual cycles. The clinic data was observed,including clinical efficacy,estradiol(E2),fol-licle-stimulating hormone (FSH),luteinizing hormone (LH),progesterone (P),hemoglobin (Hb),endometrial thickness,men-strual conditions and recurrence in 2 groups before and after treatment were observed,and the incidence of adverse reactions were recorded. RESULTS:After treatment,E2,FSH,LH and P in 2 groups were significantly lower than before,and observation group was lower than control group,the differences were statistically significant(P0.05). Total effective rate in observation group significantly higher than control group,normal proportion of menstruation were significantly better than control group,the differences were statistically sig-nificant(P0.05). CONCLUSIONS:Mifepristone cycle therapy has significant efficacy in the treatment of perimenopausal dysfunctional uterine bleeding,can significantly improve the hormone level and the establishment of normal menstrual cycle and re-duce endometrial thickness,with good safety.
ABSTRACT
Objective:To explore the clinical effect and safety of Yikunning granules combined with tibolone and paroxetine in the treatment of female patients with menopausal syndrome. Methods:Totally 150 female patients with menopausal syndrome were randomly divided into the control group (75 cases) and the study group (75 cases). The control group was orally given tibolone (2. 5mg,po,qd) and paroxetine tablets (20mg,po,qd), and the study group was treated with Yikunning granules additionally (3g,po,tid). After 3-month treatment, the modified Kupperman score was used to evaluate the clinical symptoms, radioimmunoassay was used to detect the serum lev-els of estradiol (E2), luteinizing hormone (LH), follicle stimulating hormone (FSH), prolactin (PRL) and progesterone (P), and the adverse reactions were recorded. Results:After the treatment, most of the indices in the modified Kupperman score were improved in the two groups (P0. 05). The improvement of E2, LH and FSH in the study group was better than that in the control group (P<0. 05). There was no significant difference in the adverse reactions between the two groups (P<0. 05). Conclusion:Yikunning granules combined with tibolone and paroxetine show good effectiveness in the treatment of menopausal syndrome with improved clinical symptom and sex hormone levels, which is worthy of promotion.
ABSTRACT
Primary hyperparathyroidism is the most frequent cause of hypercalcemia, and its prevalence is increasing due to the routine examination of serum calcium levels. Primary hyperparathyroidims is most commonly caused by an adenoma or hyperplasia of the parathyroid gland. A cystic parathyroid adenoma is an extremely rare cause of primary hyperparathyroidism. In our case, a-79-year old female presented with lower back pain and constipation. Her serum calcium, phosphate and immunoreactive parathyroid homone levels were 15.6, 1.8mg/dL and 371.8pg/mL, respectively. Neck CT revealed a cystic mass and a contour bulging heterogeneous mass in the left inferior right thyroid gland, respectively. These mass lesions were removed, and the intra-operative parathyroid hormone levels monitored, to confirm the complete resection. After removing the left cystic mass to the inferior thyroid, the serum calcium and immunoreactive parathyroid hormone levels quickly returned to normal. We report a case of primary hyperparathyroidism, caused by a cystic parathyroid adenoma, with a brief review of the literature
Subject(s)
Female , Humans , Adenoma , Calcium , Constipation , Hypercalcemia , Hyperparathyroidism , Hyperparathyroidism, Primary , Hyperplasia , Low Back Pain , Neck , Parathyroid Glands , Parathyroid Hormone , Parathyroid Neoplasms , Prevalence , Thyroid GlandABSTRACT
Primary hyperparathyroidism is the most frequent cause of hypercalcemia, and its prevalence is increasing due to the routine examination of serum calcium levels. Primary hyperparathyroidims is most commonly caused by an adenoma or hyperplasia of the parathyroid gland. A cystic parathyroid adenoma is an extremely rare cause of primary hyperparathyroidism. In our case, a-79-year old female presented with lower back pain and constipation. Her serum calcium, phosphate and immunoreactive parathyroid homone levels were 15.6, 1.8mg/dL and 371.8pg/mL, respectively. Neck CT revealed a cystic mass and a contour bulging heterogeneous mass in the left inferior right thyroid gland, respectively. These mass lesions were removed, and the intra-operative parathyroid hormone levels monitored, to confirm the complete resection. After removing the left cystic mass to the inferior thyroid, the serum calcium and immunoreactive parathyroid hormone levels quickly returned to normal. We report a case of primary hyperparathyroidism, caused by a cystic parathyroid adenoma, with a brief review of the literature
Subject(s)
Female , Humans , Adenoma , Calcium , Constipation , Hypercalcemia , Hyperparathyroidism , Hyperparathyroidism, Primary , Hyperplasia , Low Back Pain , Neck , Parathyroid Glands , Parathyroid Hormone , Parathyroid Neoplasms , Prevalence , Thyroid GlandABSTRACT
OBJECTIVE: To evaluate whether the basal serum luteinizing hormone (LH) levels in the presence of normal serum follicle stimulating hormone (FSH) are useful as a prognostic indicator of ovarian response to controlled ovarian hyperstimulation (COH). METHODS: From January 1997 to January 1999, 91 infertile women with tubal factor who had undergone in vitro fertilization and embryo transfer (IVF-ET) were enrolled in the present study. COH was performed using long protocol of gonadotropin-releasing hormone (GnRH) agonist. All patients included in this study had blood samples drawn on cycle day 2 or 3 prior to COH for measurement of basal FSH and LH. Women who had other infertility factors or high basal FSH levels (> or = 8.5 mIU/ml) were excluded from this study. The results of COH and IVF-ET were compared between two groups according to the level of basal LH (low LH group [ or = 3mIU/ml]). RESULTS: Patient's characteristics were comparable in both groups except basal LH level. The number of ampules and duration of exogenous gonadotropins required were significantly higher in the low LH group than those in the control group (p or = 14mm diameter on the day of human chorionic gonadotropin (hCG) injection was significantly less in the low LH group than that in the control group (p<0.001). The serum estradiol level on the day of hCG injection was also significantly lower in the low LH group, with 1115.5 +/- 380.9 pg/ml compared with 1340.6 +/- 403.0 pg/ml in the control group (p<0.005). There were significantly lower numbers in oocytes retrieved, oocytes fertilized and embryos frozen in the low LH group than those in the control group (< 0.001; < 0.001; <0.005, respectively). However, there was no difference in the fertilization rate between the two groups. The clinical pregnancy rate per cycle seemed to be lower in the low LH group, but the difference did not achieve significance (26.2% vs 39.7%). There were no differences in the miscarriage rate and multiple pregnancy rate between the two groups. CONCLUSION: This study demonstrates that the low basal LH levels ( < 3 mIU/ml) could be predictive of low ovarian response to COH and poor IVF results.
Subject(s)
Female , Humans , Pregnancy , Abortion, Spontaneous , Chorionic Gonadotropin , Embryo Transfer , Embryonic Structures , Estradiol , Fertilization , Fertilization in Vitro , Follicle Stimulating Hormone , Gonadotropin-Releasing Hormone , Gonadotropins , Infertility , Lutein , Luteinizing Hormone , Oocytes , Pregnancy Rate , Pregnancy, MultipleABSTRACT
The current classification of pituitary adenomas is based on cell type, largely ascertained by immunohistochemistry and electron microscopy. In an application of immunohistochemistry, pathologists have some problems in judging the results. An immunostaining result does not always correspond with a serum hormone level. It is also difficult to determine the nature of a tumor when a few cells are positive. We performed the immunohistochemical stains on 34 pituitary adenomas using polyclonal antibodies to six pituitary hormones [PRL (prolactin), GH (growth hormone), ACTH (adrenocorticotropic hormone), FSH (follicle-stimulating hormone), LH (luteinizing hormone), TSH (thyroid-stimulating hormone)] and compared with serum hormone level. The serum hormone level was increased in 14 cases (41.2%) of PRL, 7 cases (20.6%) of PRL & GH, 6 pleurihormonal cases (17.6%), 4 nonfunctioning cases (11.8%), 2 cases (5.9%) of FSH, and 1 case (2.9%) of GH. The most common immunohistochemical type of pituitary adenoma was 10 prolactinoma cases (38.5%), followed by 7 pleurihormonal cases (26.9%), 4 null cell cases (15.4%), 3 cases of mixed PRL & GH (11.5%), 1 case of ACTH (3.8%) and 1 FSH & LH case (3.8%). The corresponding rates of the serum hormone level and immunostaining results were 94.1% in GH, 88.9% in TSH, 85.7% in LH, 82.4% in ACTH, 66.7% FSH, and 61.8% in PRL. In the immunostaining for FSH, 12 cases showed less than 5% positivity and most of them exhibited the normal serum hormone level. In conclusion, the most common elevated serum hormone and immunohistochemical type of pituitary adenoma was prolactinoma. The corresponding rate of the serum hormone level and immunostaining result was the highest in GH cell adenoma and was the lowest in prolactinoma. The cells showing less than 5% positivity seem to be entrapped normal cells.
Subject(s)
Adenoma , Adrenocorticotropic Hormone , Antibodies , Classification , Coloring Agents , Immunohistochemistry , Luteinizing Hormone , Lymphocytes, Null , Microscopy, Electron , Pituitary Hormones , Pituitary Neoplasms , ProlactinomaABSTRACT
This study was designed to evaluate the effect of estrogen to the growth of leiomyoma and the mechanism of testosterone propionate action on leiomy-oma.The levels of estrogen receptor in uterine tissud and those of estradiol and progesterone in uterine tissue and plasma were determined in 47 women with leiomyoma.The levels of estrogen receptor and estradiol in leiomyomatous tissues were 37.6?4.0 fmol/mg protein and 401.7?92.6 pg/g tissue,respectively.Both of them were higher than the corresponding levels in normal uterine tissues (P